About
Dr Ngo is a physician by training and has obtained his Master of Medicine in internal medicine in 2013. He underwent specialised medical training in Endocrinology (DFMSA) at Pitie Salpetriere Hospital in Paris, France in 2016, where he made significant contributions to projects investigating acute retinal vascular changes in individuals with severe hypertriglyceridemia and homozygous familial hypercholesterolemia following fat loading or LDL-apheresis sessions.
In 2018, Dr Ngo received the Mai Lan Kunzy scholarship to pursue his PhD at the University of Queensland. His discovery was the first to demonstrate that mycobacterial infections result in local production of oxidised cholesterols in the lung, which drives rapid macrophage infiltration via the oxysterol sensing receptor GPR183.
Following the award of his PhD in 2022, Dr Ngo continues his work within the Infection, Immunity, and Metabolism Group led by Prof Katharina Ronacher at Mater Research Institute – University of Queensland, located at the Translational Research Institute in Brisbane. His primary goal is to evaluate whether targeting GPR183 can improve outcomes for acute and chronic lung diseases, including idiopathic pulmonary fibrosis.